Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Glendale, California Clinical Trials

A listing of Glendale, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (11) clinical trials

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

The purpose of this study is to compare the efficacy and safety of a new artificial tear formulation with Systane Ultra Multidose for 90 days in participants with Dry Eye Disease (DED).

Phase

0.49 miles

Learn More »

A PK Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients

This is a randomized, two-period, cross-over Phase 2 study, comparing PK, and assessing safety and tolerability and efficacy of peripheral and central intravenous administration of melflufen in patients with RRMM. It is an international study, enrolling patients in US and Europe. The study will enroll patients following at least 2 …

Phase

0.49 miles

Learn More »

Study to Determine the Safety Tolerability and Preliminary Evidence of Efficacy of Evenamide in Patients With Chronic Schizophrenia

This is a prospective, 4-week, randomized, double-blind, placebo-controlled, study designed to evaluate the safety, tolerability, EEG effects, and preliminary efficacy of two fixed oral doses of evenamide of 7.5 mg and 15 mg bid (15 and 30 mg/day) in outpatients with chronic schizophrenia who are receiving treatment at constant doses …

Phase

2.58 miles

Learn More »

A Study of Granexin Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery

Participants that meet screening criteria will be eligible for randomization providing all other criteria are met. Participants enrolled will receive treatment based on randomization into 1 of 3 treatment arms for up to 3 days. The participants will have an additional follow-up period beyond the treatment period to assess scarring …

Phase

4.99 miles

Learn More »

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

The study aims to evaluate two, orally administered, investigational agents - PF-06865571 (DGAT2 inhibitor) and the coadministration of PF-06865571 with PF-05221304 (ACC inhibitor). This study is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement …

Phase

4.99 miles

Learn More »

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

This is a Phase 3, multicenter, randomized, double-blinded, placebo-controlled study to assess the efficacy, safety, and immunogenicity of RSVpreF or placebo (1:1 randomization) in infants born to healthy women vaccinated during pregnancy, as well as the safety and immunogenicity in the pregnant women. This will be a global study which …

Phase

5.75 miles

Learn More »

Developing Dynamic Theories for Behavior Change

Unhealthy behaviors contribute to the majority of chronic diseases, which account for 86% of all healthcare spending in the US. Despite a great deal of research, the development of behavior change interventions that are effective, scalable, and sustainable remains challenging. Recent advances in mobile sensing and smartphone-based technologies have led …

Phase N/A

6.25 miles

Learn More »

LIFT Study: A Safety Tolerability Efficacy and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

This is a Phase 2, randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, efficacy, and pharmacokinetics (PK) of TERN-101 in non-cirrhotic NASH patients.

Phase

7.64 miles

Learn More »

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate to Severe Atopic Dermatitis.

This is a randomized, double-blind, placebo-controlled, parallel-group study which is 16 weeks in duration. The study is designed to evaluate the safety and efficacy of lebrikizumab when used in combination with topical corticosteroid (TCS) treatment compared with placebo in combination with TCS treatment for moderate-to-severe atopic dermatitis.

Phase

9.08 miles

Learn More »

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

This is a randomized, double-blind, double-dummy, active-controlled, multi-center study to assess the efficacy and safety of abrocitinib 200 mg (2 x 100 mg tablets) administered orally QD compared with dupilumab 300 mg administered by subcutaneous injection every other week (as per label guidelines) in adult participants on background topical therapy, …

Phase

9.08 miles

Learn More »